PCSA logo

PCSAProcessa Pharmaceuticals Inc

$2.21
$0.04
(1.84%)
Today
Closed $2.21
$0.0036
(0.16%)
After Hours
Updated: 06:24 PM EDT
Reported EarningsAug 7
Mkt Cap$5.97M
Vol29,726.00
51

Neutral Sentiment

How do you feel about PCSA?

News
all
press releases
PCSA Stock Rallies 10% After Hours— Here’s Why
According to filings made with the Securities and Exchange Commission, several insiders bought shares of the company at a price of about $2.535 on the last day of March.
Stocktwits
News Placeholder
More News
News Placeholder
PCSA Stock Soars on Upbeat Clinical Update From Breast Cancer Study
Processa Pharmaceuticals stock jumps 122% after a phase II update shows NGC-Cap delivers higher active metabolite exposure with comparable safety in breast cancer.
Zacks
News Placeholder
Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?
Processa Pharmaceuticals' stock jumps after Phase 2 data show higher capecitabine exposure without added toxicity in metastatic breast cancer patients.read more...
Benzinga
News Placeholder
Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks Making The Biggest Moves Today
Oracle shares were down over 5% in Wednesday’s midday session after Blue Owl Capital reportedly withdrew from a $10 billion investment in the company’s new facility in Saline Township, Michigan.
Stocktwits
News Placeholder
Why Did Processa Pharmaceuticals Stock Surge 160% Today?
The company announced that early Phase 2 data showed that its NGC therapy increased cancer-fighting metabolites in patients with advanced breast cancer.
Stocktwits
<
...
1
>

Advertisement|Remove ads.